Thesis TrackerMinotaur Capital
Companies discussed, last 12 months
0 companies, monthly, latest action on the rightNo commentary in the last 12 months.
Commentary
31 Mar 2025Minotaur CapitalIPXInitiatedThe fund initiated a position in IperionX because the manager believes the company's patented HAMR and HSPT titanium production technology addresses a clear US national security need, with China and Russia controlling 70% of global titanium supply and the US wholly reliant on imports. The manager notes IperionX's process achieves yields of 50 to 80% versus 5 to 15% for traditional methods, that the company has received US$60 million in Department of Defense grants, and that Ford recently signed an $11 million supply agreement. The manager sees a credible pathway to becoming a major US titanium producer given the fully funded Virginia facility and accelerating customer adoption.
30 Nov 2024Minotaur CapitalIPXHeldThe fund manager continues to hold IperionX, noting the stock was the second largest portfolio contributor as the Trump administration's policies are expected to benefit IperionX given its exposure to onshoring of manufacturing in the U.S., tariff protection for titanium given that approximately 70% of titanium sponge comes from China and Russia, and access to government funding for domestic strategic materials production.
About Minotaur Capital
Growth Focused, Micro/Small-CapMinotaur Capital is a boutique Australian fund manager specializing in high-conviction Australian small and micro-cap equities, applying fundamental, bottom-up research to identify well-managed, growth-oriented companies before they attract wider institutional coverage. Like many specialist small-cap boutiques, the firm runs a concentrated portfolio rather than a broadly diversified one, aiming to generate outperformance by investing ahead of the market in under-researched names. Minotaur targets wholesale investors seeking dedicated exposure to the smaller end of the ASX, distinct from broad-cap or index-based Australian equity strategies. As a smaller, specialist manager, detailed public information on its founding team and precise track record is more limited than for larger institutional peers.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.